BrachytherapyRadiation InjuriesRadiotherapyRadiotherapy, ConformalRadiotherapy DosageRadiation DosageDose FractionationProstatic NeoplasmsCombined Modality TherapyDose-Response Relationship, RadiationRadiation, IonizingAntineoplastic AgentsRadiotherapy, Intensity-ModulatedTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy Planning, Computer-AssistedRadiotherapy, AdjuvantRadiation ToleranceProstate-Specific AntigenNeoplasm Recurrence, LocalAndrogen AntagonistsRadiationProstatectomyRadiation OncologyRectumRadiation ProtectionRadiotherapy, High-EnergyChemotherapy, AdjuvantDisease-Free SurvivalRadiation MonitoringRetrospective StudiesNeoplasm StagingAdenocarcinomaRectal DiseasesFollow-Up StudiesNeoplasmsCisplatinRadiometryDoxorubicinTime FactorsSurvival RateBrain NeoplasmsSurvival AnalysisCell Line, TumorPrognosisDrug Screening Assays, AntitumorTomography, X-Ray ComputedRadiation PneumonitisNeoplasms, Radiation-InducedCarcinomaIodine RadioisotopesRadiation-Sensitizing AgentsBreast NeoplasmsRadiation Injuries, ExperimentalDrug Resistance, NeoplasmRadiosurgeryApoptosisGamma RaysRadiotherapy, Computer-AssistedThyroid NeoplasmsCosmic RadiationAntineoplastic Agents, PhytogenicEtoposideCell SurvivalRadiotherapy, Image-GuidedParticle AcceleratorsAntibiotics, AntineoplasticHead and Neck NeoplasmsMagnetic Resonance ImagingPaclitaxelRadiobiologyLung NeoplasmsCarcinoma, Squamous CellChemoradiotherapyOrgans at RiskMice, NudeBackground RadiationDNA DamageCranial IrradiationCyclophosphamideRadiation-Protective AgentsIridium RadioisotopesCobalt RadioisotopesTumor Cells, CulturedXenograft Model Antitumor AssaysDrug Delivery SystemsUltraviolet RaysNeoadjuvant TherapyRadiodermatitisKaplan-Meier EstimateTumor BurdenCamptothecinRadiation EffectsFluorouracilVinblastineDose-Response Relationship, DrugCell ProliferationBleomycinAntimetabolites, AntineoplasticDrug Carriers